anti-neoplastics
November 6, 2018
Keytruda (Pambrolizumab) in Dano Health view Pembrolizumab that formerly named MK-3475 and Lambrolizumab with trade name Keytruda is a humanized antibody used in cancer immunotherapy. It was approved for the treatment of melanoma, certain subsets […]
November 6, 2018
Rituxan (Rituximab) in Dano Health view Rituximab with the trade name Rituxan is an oncology drug that interferes with the growth and spread of cancer cells […]